174 related articles for article (PubMed ID: 9151852)
21. [Gene products of human endogenous retrovirus (HERV)-K in germ cell and trophoblastic tumors].
Herbst H; Sauter M; Fuchs H; Kühler-Obbarius C; Löning T; Mueller-Lantzsch N
Verh Dtsch Ges Pathol; 1997; 81():464-70. PubMed ID: 9474889
[TBL] [Abstract][Full Text] [Related]
22. Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.
Casau AE; Vaughan JE; Lozano G; Levine AJ
J Virol; 1999 Dec; 73(12):9976-83. PubMed ID: 10559311
[TBL] [Abstract][Full Text] [Related]
23. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
Büscher K; Trefzer U; Hofmann M; Sterry W; Kurth R; Denner J
Cancer Res; 2005 May; 65(10):4172-80. PubMed ID: 15899808
[TBL] [Abstract][Full Text] [Related]
24. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors.
Herbst H; Sauter M; Mueller-Lantzsch N
Am J Pathol; 1996 Nov; 149(5):1727-35. PubMed ID: 8909261
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the human endogenous retrovirus K proteinase.
Schommer S; Sauter M; Kräusslich HG; Best B; Mueller-Lantzsch N
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():375-9. PubMed ID: 8627242
[TBL] [Abstract][Full Text] [Related]
26. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells.
Löwer R; Löwer J; Tondera-Koch C; Kurth R
Virology; 1993 Feb; 192(2):501-11. PubMed ID: 8421897
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral
Li M; Radvanyi L; Yin B; Rycaj K; Li J; Chivukula R; Lin K; Lu Y; Shen J; Chang DZ; Li D; Johanning GL; Wang-Johanning F
Clin Cancer Res; 2017 Oct; 23(19):5892-5911. PubMed ID: 28679769
[No Abstract] [Full Text] [Related]
28. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.
Perron H; Lazarini F; Ruprecht K; Péchoux-Longin C; Seilhean D; Sazdovitch V; Créange A; Battail-Poirot N; Sibaï G; Santoro L; Jolivet M; Darlix JL; Rieckmann P; Arzberger T; Hauw JJ; Lassmann H
J Neurovirol; 2005 Feb; 11(1):23-33. PubMed ID: 15804956
[TBL] [Abstract][Full Text] [Related]
29. Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.
Kraus B; Fischer K; Sliva K; Schnierle BS
Virol J; 2014 Mar; 11():58. PubMed ID: 24669861
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus.
Matthews AL; Brown J; Switzer W; Folks TM; Heneine W; Sandstrom PA
Transplantation; 1999 Apr; 67(7):939-43. PubMed ID: 10221475
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes.
Herve CA; Lugli EB; Brand A; Griffiths DJ; Venables PJ
Clin Exp Immunol; 2002 Apr; 128(1):75-82. PubMed ID: 11982593
[TBL] [Abstract][Full Text] [Related]
32. The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells.
Chan SM; Sapir T; Park SS; Rual JF; Contreras-Galindo R; Reiner O; Markovitz DM
PLoS One; 2019; 14(2):e0212970. PubMed ID: 30818388
[TBL] [Abstract][Full Text] [Related]
33. Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells.
Yi JM; Kim HM; Kim HS
J Gen Virol; 2004 May; 85(Pt 5):1203-1210. PubMed ID: 15105536
[TBL] [Abstract][Full Text] [Related]
34. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.
Kleiman A; Senyuta N; Tryakin A; Sauter M; Karseladze A; Tjulandin S; Gurtsevitch V; Mueller-Lantzsch N
Int J Cancer; 2004 Jun; 110(3):459-61. PubMed ID: 15095315
[TBL] [Abstract][Full Text] [Related]
35. SIV, STLV-I and type D retrovirus antibodies in captive rhesus macaques and immunoblot reactivity to SIV p27 in human and rhesus monkey sera.
Lairmore MD; Lerche NW; Schultz KT; Stone CM; Brown BG; Hermann LM; Yee JA; Jennings M
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1233-8. PubMed ID: 1706606
[TBL] [Abstract][Full Text] [Related]
36. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
Patience C; Takeuchi Y; Cosset FL; Weiss RA
J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
[TBL] [Abstract][Full Text] [Related]
37. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
38. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours.
Götzinger N; Sauter M; Roemer K; Mueller-Lantzsch N
J Gen Virol; 1996 Dec; 77 ( Pt 12)():2983-90. PubMed ID: 9000088
[TBL] [Abstract][Full Text] [Related]
39. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases.
Hishikawa T; Ogasawara H; Kaneko H; Shirasawa T; Matsuura Y; Sekigawa I; Takasaki Y; Hashimoto H; Hirose S; Handa S; Nagasawa R; Maruyama N
Viral Immunol; 1997; 10(3):137-47. PubMed ID: 9344336
[TBL] [Abstract][Full Text] [Related]
40. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
